Albenatide clinical trials
How each study uses albenatide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- CJC-1134-PC Injection
- 3
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. (2) · ConjuChem (2)
Studies
Open first, then newest update. How each study uses albenatide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic ControlCompletedPhase 3Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.NCT07058545Written as CJC-1134-PC Injection
- A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin SecretagoguesCompletedPhase 3Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.NCT07057271Written as CJC-1134-PC Injection
- Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin MonotherapyTerminatedPhase 2ConjuChemNCT01514149Written as CJC-1134-PC Injection
- A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin MonotherapyCompletedPhase 2ConjuChemNCT00638716Written as CJC-1134-PC
Codes
What other systems call albenatide · ClinicalTrials.gg INT033047
- UNII (FDA) 5Y7IGH3V3QALBENATIDEOne source FDA
- NCI Thesaurus C166872AlbenatideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5Y7IGH3V3Q | ALBENATIDE | One source FDA |
| NCI Thesaurus | C166872 | Albenatide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.